Dáil Éireann Debate, Thursday - 22 January 2015
138. Deputy Billy Kelleher asked the Minister for Health if the Health Service Executive has held a meeting with a company (details supplied) over the past three months to discuss the pricing issue of its product Eculizumab; the outcome of these discussions; if not, the efforts that the HSE is making to secure a price structure; and if he will make a statement on the matter. [3097/15]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to you. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.
